<?xml version="1.0" encoding="UTF-8"?>
<ack id="jia225048-sec-0026">
 <title>Acknowledgements</title>
 <p>We are grateful to the following group of trial researchers with whom the early results of the study were discussed in a meeting held in July 2016 in Durban, South Africa: Joseph Makhema, Kathleen Powis (BCPP), Shaukat Khan, Charlotte Lejeune, Emma Mafara, Sikhathele Mazibuko, Charmaine Khudzie Mlambo, Ria Reis, Donna Spiegelman (
  <italic>Max</italic>ART), Janet Seeley (PopART), Carol Camlin, Edwin Charlebois, (SEARCH), Joseph Larmarange and Mélanie Plazy (ANRS TasP).
 </p>
 <p>We would like to thank the trial PIs: Pamela Bachanas, Shenaaz El Halabi, Myron Essex, Refeletswe Lebelonyane, Shahin Lockman, Joseph Makhema, Tafireyi Marukutira, Lisa A. Mills, Janet Moore, Molly Pretorius Holme, Eric Tchetgen Tchetgen (BCPP), Velephi Okello (
  <italic>Max</italic>ART), Helen Ayles, Nulda Beyers, Peter Bock, Sarah Fidler, Richard Hayes (PopART), Diane Havlir, Moses Kamya, Maya Petersen (SEARCH), François Dabis, Marie‐Louise Newell and Deenan Pillay (ANRS TasP). We also thank Varsha Surampudi and Lisa Patton (Social &amp; Scientific Systems, Inc (SSS)) for their technical assistance with the UT
  <sup>3</sup>C working group, as well as Deborah Birx, United States Global AIDS Coordinator, for taking part in the initial idea of forming the UT
  <sup>3</sup>C working group.
 </p>
 <p>We finally thank the Ministries of Health of Botswana, Kenya, South Africa, Swaziland, Uganda and Zambia, the trial research teams, collaborators and advisory boards, the funding agencies and all communities and participants involved.</p>
</ack>
